MARY WARD: Open Payments
NPI 1821278813 · MERIDIAN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 22 payments from 12 companies in 2025. Trend: 2023 $226 · 2024 $298 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 4 | $102 |
| Abbott Laboratories | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| Tandem Diabetes Care, Inc. | 2 | $40 |
| Averitas Pharma Inc. | 1 | $37 |
| Lilly USA, LLC | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Sequel Med Tech, LLC | 1 | $19 |
| Madrigal Pharmaceuticals | 1 | $18 |
Products named: Korlym, FREESTYLE LIBRE 3, Kerendia, t:slim X2 Insulin Pump with Control-IQ, QUTENZA, MOUNJARO, FARXIGA, JARDIANCE.
Industry payments across MS — which companies pay providers there.
